# Safety and Efficacy of Drug-Coated Balloon for De-novo Lesions in Patients With Acute Coronary Syndromes (DCB-ACS)

> **NCT04937803** · NA · COMPLETED · sponsor: **Harbin Medical University** · enrollment: 216 (actual)

## Conditions studied

- Drug-Coated Balloon
- De Novo Stenosis
- Acute Coronary Syndromes
- ACS
- DCB
- Clinical Trial
- Coronary Artery Disease

## Interventions

- **DEVICE:** Drug-coated balloon
- **DEVICE:** Zotarolimus-Eluting Coronary Stent

## Key facts

- **NCT ID:** NCT04937803
- **Lead sponsor:** Harbin Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-19
- **Primary completion:** 2023-02-18
- **Final completion:** 2023-11-17
- **Target enrollment:** 216 (ACTUAL)
- **Last updated:** 2024-07-17

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04937803

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04937803, "Safety and Efficacy of Drug-Coated Balloon for De-novo Lesions in Patients With Acute Coronary Syndromes (DCB-ACS)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04937803. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*